Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Joe Copia's daytrades/investments and thoughts -- Ignore unavailable to you. Want to Upgrade?

To: IronMill who wrote (19306)	8/25/1999 12:05:00 PM
From: Joe Copia	Respond to of 25711

more info on WASP: Wednesday August 11, 1:00 pm Eastern Time Company Press Release Wasatch Pharmaceutical Announces Foreign and Domestic Licensing MIDVALE, Utah--(BUSINESS WIRE)--Aug. 11, 1999--As previously announced, Wasatch (OTC BB:WASP) has begun the application process with the FDA for over-the-counter approvals on seven of its products. After an update from FDA regulators, it is anticipated that approvals could come within the next twelve to fourteen months. With a focus on the U.S. domestic market, Wasatch has not overtly pursued foreign licensing. We are pleased to announce that this policy will change as a result of requests from medical and retail entities having a strong presence in Brazil, New Zealand and Australia. With existing ancillary products, soaps and skin moisturizers, Wasatch is in a position to make these superior products available to the general public in these countries and the US market. No FDA approvals are needed for over-the-counter use of these products. Therefore, licensing in these countries and the US will be actively nurtured with existing contacts for products that are ready for market. With a less than one percent sensitivity reaction to these products, the general public will be able to have access to these products previously available only to patients in medical clinics owned by Wasatch Pharmaceutical. These products will be a welcome relief to those in the general population who cannot use existing over-the-counter soaps and creams. Licensing agreements for these products will prove to be a strong source of revenue to Wasatch. And with FDA approvals anticipated on the seven other OTC products, we feel licensing of products will play a major role in our overall presence in the OTC market. NOTE: Any statements released by Wasatch Pharmaceutical Inc. that are not strictly historical are forward-looking statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Editors and investors are cautioned that forward-looking statements invoke risk and uncertainties that may affect the companys business prospects and performance. These include economic, competitive, governmental, technological and other factors discussed in the companys filings with the Securities and Exchange Commission. Contact: Wasatch Pharmaceutical Inc., Midvale Gary Heesch, 801/272-1709

To: IronMill who wrote (19306)	8/25/1999 12:21:00 PM
From: IronMill	Read Replies (1) \| Respond to of 25711

PFSD PFSD : PACIFIC SANDS INC (OTC) All Headlines Pacific Sands Inc. Announces Its Product Evaluation by the Wal-Mart WIN Program CLOVIS, Calif.--(BUSINESS WIRE)--Aug. 25, 1999--The company (OTC BB: PFSD) announced that their product had been sent through the Wal-Mart Innovation Network WIN Program at the Southwest Missouri State University. It was no surprise to them that it had scored the highest score in the past 22 years. Let me give you a few quotes from Dr. Gerald G. Udell, who developed the WIN Program 22 years ago. Dr. Udell said, "To the best of his recollection only one or two other inventions have received scores this high and none have exceeded this rating. Under the PIES (Preliminary Innovation Evaluation System) format the maximum rating is .50 and we are exceedingly miserly with the top .20 percent of the scale. Only about 10-15% of the inventions reach the .40 mark and only 6% reach .42 and are referred to Wal-Mart. Last year only 1 of about 400 inventions reached the .43 mark. I have assigned an SLR of .475 to Natural Water Technology." Speaking to the flexibility of the product Dr. Udell says, "The application of this technology is exceedingly wide, ranging from the clean-up of gold mine tailings, to baby's diapers, to the food we eat, to the sewage we produce in abundance. Not a week has gone by that some new use has occurred to us. The possibility of industrial, institutional and consumer uses for this technology is immense." "There is no such thing as a fail safe technology, but technologies like yours come pretty close to the mark. The reason is simple. In contrast to most inventions which are dependent upon a single potential market application for commercial success, this technology has numerous possibilities for success, thereby reducing the risk associated with commercialization quite substantially. Few technological innovations have so many potential applications and therefore, so many opportunities for success." It is the intent of Pacific Sands to leverage this evaluation of its products into the retail market. We are currently negotiating with multiple sales organizations for the purpose of launching our Pool, Spa, and Pet Products. This release is covered under the "Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Certain information included in this release that are not historical facts are forward looking statements that involve a number of known and unknown ricks and uncertainties, including but not limited to, the company's ability to successfully implement a strategy of continued growth. The company's actual results, performance or achievements may differ materially from any future results, performance or achievements expressed or implies in any forward-looking statemen